Vision Institute

Colorado Springs, Colorado 80907

1 studies enrolling now · 20 studies all time

What they study most

Allergic Conjunctivitis, Blepharitis, Demodex Blepharitis, Dry Eye, Dry Eye Disease, Dry Eye Disease (DED), Dry Eye Syndromes, Eye Irritation, Meibomian Gland Dysfunction, Neurotrophic Keratitis, Neurotrophic Keratopathy, Ocular Redness

Studies at this site

• A Clinical Study Evaluating Licaminlimab for Dry Eye Disease — Recruiting now
• Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects — Completed
• A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes — Completed
• An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations — Completed
• Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) — Completed
• Study Evaluating the Safety and Efficacy of AR-15512 — Completed
• Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers — Completed
• Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease — Completed
• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease — Completed
• A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease — Completed
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease — Completed
• Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1) — Completed
• The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• A Study of TL-925 as a Treatment for Dry Eye Disease — Completed
• Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1 — Stopped early
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 — Completed
• A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis — Completed
• Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye Disease — Stopped early